Ionis Pharma (IONS) Misses Q3 EPS by 2c

Ionis Pharma (NASDAQ: IONS) reported Q3 EPS of $0.06, $0.02 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $110.9 million versus the consensus estimate of $113.09 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Ionis Pharmaceuticals (IONS) PT Raised to $130 at H.C. Wainwright
• Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
• Hyperscale Data acquires 48.5 acres to expand Michigan campus